These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 19836170

  • 1. Is ecstasy a drug of dependence?
    Degenhardt L, Bruno R, Topp L.
    Drug Alcohol Depend; 2010 Feb 01; 107(1):1-10. PubMed ID: 19836170
    [Abstract] [Full Text] [Related]

  • 2. Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
    Allott K, Redman J.
    Neurosci Biobehav Rev; 2007 Feb 01; 31(3):327-47. PubMed ID: 17109962
    [Abstract] [Full Text] [Related]

  • 3. Club drug use in Germany.
    Soellner R.
    Subst Use Misuse; 2005 Feb 01; 40(9-10):1279-93. PubMed ID: 16048817
    [Abstract] [Full Text] [Related]

  • 4. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
    Clemens KJ, McGregor IS, Hunt GE, Cornish JL.
    Drug Alcohol Rev; 2007 Jan 01; 26(1):9-15. PubMed ID: 17364831
    [Abstract] [Full Text] [Related]

  • 5. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Sumnall HR, Cole JC, Jerome L.
    J Psychopharmacol; 2006 Sep 01; 20(5):670-82. PubMed ID: 16401654
    [Abstract] [Full Text] [Related]

  • 6. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar 01; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 7. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan 01; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 8. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E, Daumann J.
    Addiction; 2006 Mar 01; 101(3):348-61. PubMed ID: 16499508
    [Abstract] [Full Text] [Related]

  • 9. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G, Bailly D, Boss V, Thomas P, Lestavel P, Goudemand M.
    Encephale; 2001 Mar 01; 27(2):198-202. PubMed ID: 11407274
    [Abstract] [Full Text] [Related]

  • 10. Can the severity of dependence scale be usefully applied to 'ecstasy'?
    Bruno R, Matthews AJ, Topp L, Degenhardt L, Gomez R, Dunn M.
    Neuropsychobiology; 2009 Mar 01; 60(3-4):137-47. PubMed ID: 19893331
    [Abstract] [Full Text] [Related]

  • 11. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar 01; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 12. Recent trends in the use of "club drugs": an Australian review.
    Degenhardt L, Copeland J, Dillon P.
    Subst Use Misuse; 2005 Mar 01; 40(9-10):1241-56. PubMed ID: 16048815
    [Abstract] [Full Text] [Related]

  • 13. Evidence for executive deficits among users of MDMA (Ecstasy).
    Fisk JE, Montgomery C, Murphy P, Wareing M.
    Br J Psychol; 2004 Nov 01; 95(Pt 4):457-66. PubMed ID: 15527532
    [Abstract] [Full Text] [Related]

  • 14. Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users.
    Verheyden SL, Henry JA, Curran HV.
    Hum Psychopharmacol; 2003 Oct 01; 18(7):507-17. PubMed ID: 14533132
    [Abstract] [Full Text] [Related]

  • 15. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J.
    Drug Alcohol Depend; 2005 Jun 01; 78(3):317-23. PubMed ID: 15893163
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B, Day C, Degenhardt L, Kinner S, Fry C, Bruno R, Johnston J.
    Drug Alcohol Depend; 2006 Jul 27; 83(3):210-7. PubMed ID: 16343810
    [Abstract] [Full Text] [Related]

  • 17. [Psychological aspects of MDMA (ecstasy) users].
    Varescon I.
    Ann Med Interne (Paris); 2003 Nov 27; 154 Spec No 2():S81-5. PubMed ID: 14760230
    [Abstract] [Full Text] [Related]

  • 18. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ.
    Psychopharmacology (Berl); 2002 Jul 27; 162(2):203-14. PubMed ID: 12110998
    [Abstract] [Full Text] [Related]

  • 19. A review of the acute subjective effects of MDMA/ecstasy.
    Baylen CA, Rosenberg H.
    Addiction; 2006 Jul 27; 101(7):933-47. PubMed ID: 16771886
    [Abstract] [Full Text] [Related]

  • 20. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.
    Parrott AC.
    J Psychopharmacol; 2005 Jan 27; 19(1):71-83. PubMed ID: 15671132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.